Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
GlobeNewswire
· *Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular..